Piper Sandler analyst Luke Lemoine raised the firm’s price target on ChampionX (CHX) to $40 from $32 and keeps a Neutral rating on the shares, citing SLB‘s (SLB) takeout offer. The firm notes there was some investor pushback on SLB buying “just” chemicals and lift, but it believes this needs to be reframed a good bit and needs to be characterized as production optimization and reservoir recovery — two themes that Piper thinks will be major drivers over the next few years.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHX:
- ChampionX price target raised to $51 from $39 at Barclays
- SLB price target raised to $69 from $66 at RBC Capital
- M&A News: SLB Acquires ChampionX for $8 Billion
- SLB announces agreement to acquire ChampionX in all-stock transaction
- SLB Announces Agreement to Acquire ChampionX in an All-Stock Transaction